「风雨健康之行」厉害了! O药获批胃癌+O药援助计划, “胃”来免疫治疗触手可及( 二 )
注:
*伊匹木单抗(Ipilimumab/Yervoy)尚未在中国大陆获批上市
*目前纳武利尤单抗黑色素瘤以及肝细胞癌适应症尚未在中国获批
参考文献
[1
Chen L-T. et al. A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION 2): 2 year update data [J
. Gastric Cancer 2019(19).
[2
Kang YK et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to or intolerant of at least two previous chemotherapy regimens (ONO-4538-12 ATTRACTION-2): a randomised double-blind placebo-controlled phase 3 trial. Lancet. 2017 Dec 2;390(10111):2461-2471. doi: 10.1016/S0140-6736(17)31827-5. Epub 2017 Oct 6.
[3
Chao Y et al. Nivolumab in Advanced Gastric or Gastroesophageal Junction Cancer Refractory to or Intolerant of at Least Two Previous Chemotherapy Regimens: a Taiwanese Subgroup Analysis of ATTRACTION-2 Study. Presented at the GEST (2019) Gastroenterological Society of Taiwan - 2019 Annual Meeting
推荐阅读
- 【寒潮】 专家教你如何打好健康保卫战 寒潮在路上
- 湖南东安“夫妻档”村医守护村民健康20载
- 湖北兴山一村医扎根深山30年:当好“健康守门人”
- 健康■动起来!第三届健康江苏健步走来了
- 特斯拉|热评 | 加强OTA技术召回监管将有助于汽车产业健康发展
- |香港前女首富朱李月华成功升级当奶奶,小婴儿七斤多健康可爱
- 趣头条|#敢发就敢送#贴心黑猫 ,风雨同行,低温不是考验,做冬日暖阳
- 贾玲|贾玲爆肥后现身工作室,脸大到肉都溢出来了,身体健康引担忧
- 2020南京国际生命健康科技大会12月9日举行
- |大咖名企云集,亮点纷呈 2020南京国际生命健康科技大会12月9日举行
